KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001348911

SEC filings (opens in a new tab)

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of KALV: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	128	1	140	+13
Shares	54.9M	265	54.4M	−474.5K (−0.9%)
Value	$633.7M	$3.06K	$615.5M	−$18.1M (−2.9%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to KALV in Q2 2025
Institution	Shares	Value	% of portfolio
First Turn Management, LLC	214,138	$2.42M	0.45%
Ikarian Capital, LLC	198,528	$2.24M	0.74%
Nan Fung Trinity (HK) Ltd	154,522	$1.75M	0.21%
Boothbay Fund Management, LLC	148,927	$1.68M	0.05%
Raymond James Financial Inc	101,035	$1.14M	0.00%
Qube Research & Technologies Ltd	97,248	$1.10M	0.00%
Boxer Capital Management, LLC	93,400	$1.06M	0.53%
Susquehanna Portfolio Strategies, LLC	92,259	$1.04M	0.02%
Jane Street Group, LLC	54,910	$620.8K	0.00%
Omers Administration Corp	33,900	$383.2K	0.00%
Virtu Financial LLC	30,739	$347.0K	0.02%
Squarepoint Ops LLC	26,386	$298.3K	0.00%
Advisor Group Holdings, Inc.	21,915	$247.6K	0.00%
Quadrature Capital Ltd	19,973	$225.9K	0.00%
Atom Investors LP	16,312	$184.4K	0.02%
Citadel Advisors LLC	15,841	$179.1K	0.00%
Brevan Howard Capital Management LP	13,333	$150.7K	0.00%
Trexquant Investment LP	12,781	$144.5K	0.00%
Whalen Wealth Management Inc.	10,938	$123.7K	0.08%
Profund Advisors LLC	10,020	$113.3K	0.00%
Virtus Investment Advisers, Inc.	7,184	$81.2K	0.03%
Group One Trading, L.P.	4,963	$56.1K	0.00%
Simplex Trading, LLC	3,543	$40.0K	0.00%
Truvestments Capital LLC	1,324	$15.0K	0.00%
Quest Partners LLC	131	$1.48K	0.00%
Toth Financial Advisory Corp	100	$1.13K	0.00%
UMA Financial Services, Inc.	51	$577	0.00%
Parkside Financial Bank & Trust	40	$453	0.00%
Essential Partners LLC	38	$430	0.00%
Parkworth Wealth Management, Inc.	22	$249	0.00%

Sold out (17)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of KALV in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Jefferies Financial Group Inc.	375,000	$4.33M
Adage Capital Partners GP, L.L.C.	276,000	$3.19M
Walleye Capital LLC	249,161	$2.88M
Nan Fung Group Holdings Ltd	154,522	$1.78M
Diadema Partners LP	135,509	$1.56M
Persistent Asset Partners Ltd	34,098	$393.5K
HighVista Strategies LLC	33,305	$384.3K
PDT Partners, LLC	23,654	$273.0K
Corebridge Financial, Inc.	19,094	$220.3K
Ieq Capital, LLC	10,915	$126.0K
ProShare Advisors LLC	10,666	$123.1K
Quadrant Capital Group LLC	337	$3.89K
Smartleaf Asset Management LLC	279	$3.33K
Caitong International Asset Management Co., Ltd	157	$1.81K
Coldstream Capital Management Inc	69	$797
Stephens Consulting, LLC	30	$347
Capital Performance Advisors LLP	3,845	–

Not filed for Q2 2025 yet (1)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KALV in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Lindbrook Capital, LLC	265	$3.06K